6533b851fe1ef96bd12aa252

RESEARCH PRODUCT

Immune status towards Epstein-Barr virus in a group of Sicilian children.

R. Di StefanoF. SammartanoSerenella AristaP. FormicaP. AmmatunaA. AlbeggianiL. Bellia

subject

medicine.medical_specialtyHerpesvirus 4 HumanMononucleosisEpidemiologyFluorescent Antibody Techniquemedicine.disease_causeAntibodies ViralSerologyAntigenhemic and lymphatic diseasesEpidemiologymedicineHumansSerologic TestsInfectious MononucleosisChildAntigens ViralCell Nucleusbiologybusiness.industryAge FactorsInfant NewbornInfantmedicine.diseaseEpstein–Barr virusVirologyImmunoglobulin ATiterCapsidEpstein-Barr Virus Nuclear AntigensImmunoglobulin MItalyChild PreschoolImmunoglobulin GImmunologybiology.proteinAntibodybusiness

description

The prevalence of antibodies to Epstein-Barr virus-determined antigens was studied in 17 children with acute infectious mononucleosis (IM) and in 263 children hospitalized for diseases unrelated to EBV infection. Antibodies against Epstein-Barr viral capsid antigens (VCA) were observed in 173 patients of the control group (66%), but 58 of them (33,5%) had not yet developed antibodies against Epstein-Barr virus-associated nuclear antigen (EBNA). IgM-specific antibodies were not found in any of the children of the control group but were present in all of the 17 patients with IM. The rates of positivity for IgA anti-VCA and IgG anti-early antigen (EA) were similar in all age groups. Anti-viral capsid antigen IgG seropositivity increased to 83% by the age of six years, the mean geometric titre being highest between the ages of 2 and 4 years. Our results suggest that in Sicilian children the primary infection occurs prevalently early in life, in parallel with the occurrence of IM.

10.1007/bf00156834https://pubmed.ncbi.nlm.nih.gov/2548891